img

Global Biologic Therapeutic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biologic Therapeutic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Biologic Therapeutic Drug are used for treatment of numerous diseases and conditions, and are the most advanced therapies.
Biologic Therapeutic Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biologic Therapeutic Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinical Medicine and Laboratory are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biologic Therapeutic Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biologic Therapeutic Drug key companies include Aurobindo Pharma Ltd., Concord Biotech, GlaxoSmithKline Plc., H. Lundbeck A/S, Novartis Global, Retractable Technologies, Inc., Smith Medical, AstraZeneca and Pfizer Inc., etc. Aurobindo Pharma Ltd., Concord Biotech, GlaxoSmithKline Plc. are top 3 players and held % share in total in 2022.
Biologic Therapeutic Drug can be divided into Monoclonal Antibodies, Therapeutic Proteins and Vaccines,, etc. Monoclonal Antibodies is the mainstream product in the market, accounting for % share globally in 2022.
Biologic Therapeutic Drug is widely used in various fields, such as Clinical Medicine, Laboratory and Others,, etc. Clinical Medicine provides greatest supports to the Biologic Therapeutic Drug industry development. In 2022, global % share of Biologic Therapeutic Drug went into Clinical Medicine filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biologic Therapeutic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Aurobindo Pharma Ltd.
Concord Biotech
GlaxoSmithKline Plc.
H. Lundbeck A/S
Novartis Global
Retractable Technologies, Inc.
Smith Medical
AstraZeneca
Pfizer Inc.
Merck and Co. Inc.
Segment by Type
Monoclonal Antibodies
Therapeutic Proteins
Vaccines

Segment by Application


Clinical Medicine
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biologic Therapeutic Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biologic Therapeutic Drug introduction, etc. Biologic Therapeutic Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Biologic Therapeutic Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Biologic Therapeutic Drug
1.1 Biologic Therapeutic Drug Market Overview
1.1.1 Biologic Therapeutic Drug Product Scope
1.1.2 Biologic Therapeutic Drug Market Status and Outlook
1.2 Global Biologic Therapeutic Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Biologic Therapeutic Drug Market Size by Region (2024-2034)
1.4 Global Biologic Therapeutic Drug Historic Market Size by Region (2024-2024)
1.5 Global Biologic Therapeutic Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Biologic Therapeutic Drug Market Size (2024-2034)
1.6.1 North America Biologic Therapeutic Drug Market Size (2024-2034)
1.6.2 Europe Biologic Therapeutic Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Biologic Therapeutic Drug Market Size (2024-2034)
1.6.4 Latin America Biologic Therapeutic Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Biologic Therapeutic Drug Market Size (2024-2034)
2 Biologic Therapeutic Drug Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Therapeutic Proteins
2.1.3 Vaccines
2.2 Global Biologic Therapeutic Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Biologic Therapeutic Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Biologic Therapeutic Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Biologic Therapeutic Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Biologic Therapeutic Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Biologic Therapeutic Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Biologic Therapeutic Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Biologic Therapeutic Drug Revenue Breakdown by Type (2024-2034)
3 Biologic Therapeutic Drug Market Overview by Application
3.1 Introduction
3.1.1 Clinical Medicine
3.1.2 Laboratory
3.1.3 Others
3.2 Global Biologic Therapeutic Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Biologic Therapeutic Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Biologic Therapeutic Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Biologic Therapeutic Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Biologic Therapeutic Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Biologic Therapeutic Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Biologic Therapeutic Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Biologic Therapeutic Drug Revenue Breakdown by Application (2024-2034)
4 Biologic Therapeutic Drug Competition Analysis by Players
4.1 Global Biologic Therapeutic Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologic Therapeutic Drug as of 2022)
4.3 Date of Key Players Enter into Biologic Therapeutic Drug Market
4.4 Global Top Players Biologic Therapeutic Drug Headquarters and Area Served
4.5 Key Players Biologic Therapeutic Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Biologic Therapeutic Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Aurobindo Pharma Ltd.
5.1.1 Aurobindo Pharma Ltd. Profile
5.1.2 Aurobindo Pharma Ltd. Main Business
5.1.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Products, Services and Solutions
5.1.4 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.1.5 Aurobindo Pharma Ltd. Recent Developments
5.2 Concord Biotech
5.2.1 Concord Biotech Profile
5.2.2 Concord Biotech Main Business
5.2.3 Concord Biotech Biologic Therapeutic Drug Products, Services and Solutions
5.2.4 Concord Biotech Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.2.5 Concord Biotech Recent Developments
5.3 GlaxoSmithKline Plc.
5.3.1 GlaxoSmithKline Plc. Profile
5.3.2 GlaxoSmithKline Plc. Main Business
5.3.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Products, Services and Solutions
5.3.4 GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.3.5 H. Lundbeck A/S Recent Developments
5.4 H. Lundbeck A/S
5.4.1 H. Lundbeck A/S Profile
5.4.2 H. Lundbeck A/S Main Business
5.4.3 H. Lundbeck A/S Biologic Therapeutic Drug Products, Services and Solutions
5.4.4 H. Lundbeck A/S Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.4.5 H. Lundbeck A/S Recent Developments
5.5 Novartis Global
5.5.1 Novartis Global Profile
5.5.2 Novartis Global Main Business
5.5.3 Novartis Global Biologic Therapeutic Drug Products, Services and Solutions
5.5.4 Novartis Global Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.5.5 Novartis Global Recent Developments
5.6 Retractable Technologies, Inc.
5.6.1 Retractable Technologies, Inc. Profile
5.6.2 Retractable Technologies, Inc. Main Business
5.6.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Products, Services and Solutions
5.6.4 Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.6.5 Retractable Technologies, Inc. Recent Developments
5.7 Smith Medical
5.7.1 Smith Medical Profile
5.7.2 Smith Medical Main Business
5.7.3 Smith Medical Biologic Therapeutic Drug Products, Services and Solutions
5.7.4 Smith Medical Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.7.5 Smith Medical Recent Developments
5.8 AstraZeneca
5.8.1 AstraZeneca Profile
5.8.2 AstraZeneca Main Business
5.8.3 AstraZeneca Biologic Therapeutic Drug Products, Services and Solutions
5.8.4 AstraZeneca Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.8.5 AstraZeneca Recent Developments
5.9 Pfizer Inc.
5.9.1 Pfizer Inc. Profile
5.9.2 Pfizer Inc. Main Business
5.9.3 Pfizer Inc. Biologic Therapeutic Drug Products, Services and Solutions
5.9.4 Pfizer Inc. Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.9.5 Pfizer Inc. Recent Developments
5.10 Merck and Co. Inc.
5.10.1 Merck and Co. Inc. Profile
5.10.2 Merck and Co. Inc. Main Business
5.10.3 Merck and Co. Inc. Biologic Therapeutic Drug Products, Services and Solutions
5.10.4 Merck and Co. Inc. Biologic Therapeutic Drug Revenue (US$ Million) & (2024-2024)
5.10.5 Merck and Co. Inc. Recent Developments
6 North America
6.1 North America Biologic Therapeutic Drug Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Biologic Therapeutic Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biologic Therapeutic Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biologic Therapeutic Drug Market Dynamics
11.1 Biologic Therapeutic Drug Industry Trends
11.2 Biologic Therapeutic Drug Market Drivers
11.3 Biologic Therapeutic Drug Market Challenges
11.4 Biologic Therapeutic Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Biologic Therapeutic Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Biologic Therapeutic Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Biologic Therapeutic Drug Market Size Share by Region (2024-2024)
Table 4. Global Biologic Therapeutic Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Biologic Therapeutic Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Biologic Therapeutic Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Biologic Therapeutic Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Biologic Therapeutic Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Biologic Therapeutic Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Biologic Therapeutic Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Biologic Therapeutic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Biologic Therapeutic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Biologic Therapeutic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Biologic Therapeutic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Biologic Therapeutic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Biologic Therapeutic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Biologic Therapeutic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Biologic Therapeutic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Biologic Therapeutic Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Biologic Therapeutic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Biologic Therapeutic Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Biologic Therapeutic Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Biologic Therapeutic Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Biologic Therapeutic Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Biologic Therapeutic Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Biologic Therapeutic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Biologic Therapeutic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Biologic Therapeutic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Biologic Therapeutic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Biologic Therapeutic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Biologic Therapeutic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Biologic Therapeutic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Biologic Therapeutic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Biologic Therapeutic Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Biologic Therapeutic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Biologic Therapeutic Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Biologic Therapeutic Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologic Therapeutic Drug as of 2022)
Table 39. Date of Key Players Enter into Biologic Therapeutic Drug Market
Table 40. Global Biologic Therapeutic Drug Key Players Headquarters and Area Served
Table 41. Biologic Therapeutic Drug Product Solution and Service
Table 42. Global Biologic Therapeutic Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Aurobindo Pharma Ltd. Basic Information List
Table 45. Aurobindo Pharma Ltd. Description and Business Overview
Table 46. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Biologic Therapeutic Drug Business of Aurobindo Pharma Ltd. (2024-2024)
Table 48. Aurobindo Pharma Ltd. Recent Developments
Table 49. Concord Biotech Basic Information List
Table 50. Concord Biotech Description and Business Overview
Table 51. Concord Biotech Biologic Therapeutic Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Biologic Therapeutic Drug Business of Concord Biotech (2024-2024)
Table 53. Concord Biotech Recent Developments
Table 54. GlaxoSmithKline Plc. Basic Information List
Table 55. GlaxoSmithKline Plc. Description and Business Overview
Table 56. GlaxoSmithKline Plc. Biologic Therapeutic Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Biologic Therapeutic Drug Business of GlaxoSmithKline Plc. (2024-2024)
Table 58. GlaxoSmithKline Plc. Recent Developments
Table 59. H. Lundbeck A/S Basic Information List
Table 60. H. Lundbeck A/S Description and Business Overview
Table 61. H. Lundbeck A/S Biologic Therapeutic Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Biologic Therapeutic Drug Business of H. Lundbeck A/S (2024-2024)
Table 63. H. Lundbeck A/S Recent Developments
Table 64. Novartis Global Basic Information List
Table 65. Novartis Global Description and Business Overview
Table 66. Novartis Global Biologic Therapeutic Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Biologic Therapeutic Drug Business of Novartis Global (2024-2024)
Table 68. Novartis Global Recent Developments
Table 69. Retractable Technologies, Inc. Basic Information List
Table 70. Retractable Technologies, Inc. Description and Business Overview
Table 71. Retractable Technologies, Inc. Biologic Therapeutic Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Biologic Therapeutic Drug Business of Retractable Technologies, Inc. (2024-2024)
Table 73. Retractable Technologies, Inc. Recent Developments
Table 74. Smith Medical Basic Information List
Table 75. Smith Medical Description and Business Overview
Table 76. Smith Medical Biologic Therapeutic Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Biologic Therapeutic Drug Business of Smith Medical (2024-2024)
Table 78. Smith Medical Recent Developments
Table 79. AstraZeneca Basic Information List
Table 80. AstraZeneca Description and Business Overview
Table 81. AstraZeneca Biologic Therapeutic Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Biologic Therapeutic Drug Business of AstraZeneca (2024-2024)
Table 83. AstraZeneca Recent Developments
Table 84. Pfizer Inc. Basic Information List
Table 85. Pfizer Inc. Description and Business Overview
Table 86. Pfizer Inc. Biologic Therapeutic Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Biologic Therapeutic Drug Business of Pfizer Inc. (2024-2024)
Table 88. Pfizer Inc. Recent Developments
Table 89. Merck and Co. Inc. Basic Information List
Table 90. Merck and Co. Inc. Description and Business Overview
Table 91. Merck and Co. Inc. Biologic Therapeutic Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Biologic Therapeutic Drug Business of Merck and Co. Inc. (2024-2024)
Table 93. Merck and Co. Inc. Recent Developments
Table 94. North America Biologic Therapeutic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 95. North America Biologic Therapeutic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 96. Europe Biologic Therapeutic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 97. Europe Biologic Therapeutic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 98. Asia-Pacific Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 99. Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2024-2024) & (US$ Million)
Table 100. Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2024-2034) & (US$ Million)
Table 101. Asia-Pacific Biologic Therapeutic Drug Market Share by Region (2024-2024)
Table 102. Asia-Pacific Biologic Therapeutic Drug Market Share by Region (2024-2034)
Table 103. Latin America Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 104. Latin America Biologic Therapeutic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 105. Latin America Biologic Therapeutic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 106. Middle East & Africa Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 107. Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2024-2024) & (US$ Million)
Table 108. Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 109. Biologic Therapeutic Drug Market Trends
Table 110. Biologic Therapeutic Drug Market Drivers
Table 111. Biologic Therapeutic Drug Market Challenges
Table 112. Biologic Therapeutic Drug Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Therapeutic Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Biologic Therapeutic Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Biologic Therapeutic Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Biologic Therapeutic Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Biologic Therapeutic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Biologic Therapeutic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Biologic Therapeutic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Biologic Therapeutic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Biologic Therapeutic Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Monoclonal Antibodies
Figure 11. Global Monoclonal Antibodies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Therapeutic Proteins
Figure 13. Global Therapeutic Proteins Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Vaccines
Figure 15. Global Vaccines Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Biologic Therapeutic Drug Market Size Share by Type: 2022 & 2034
Figure 17. North America Biologic Therapeutic Drug Revenue Market Share by Type (2024-2034)
Figure 18. Europe Biologic Therapeutic Drug Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Biologic Therapeutic Drug Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Biologic Therapeutic Drug Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Biologic Therapeutic Drug Revenue Market Share by Type (2024-2034)
Figure 22. Clinical Medicine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Laboratory Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Biologic Therapeutic Drug Market Size Share by Application: 2022 & 2034
Figure 26. North America Biologic Therapeutic Drug Revenue Market Share by Application (2024-2034)
Figure 27. Europe Biologic Therapeutic Drug Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Biologic Therapeutic Drug Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Biologic Therapeutic Drug Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Biologic Therapeutic Drug Revenue Market Share by Application (2024-2034)
Figure 31. Biologic Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Biologic Therapeutic Drug Market Share in 2022
Figure 33. North America Biologic Therapeutic Drug Market Share by Country (2024-2034)
Figure 34. United States Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 37. France Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Biologic Therapeutic Drug Market Share by Region (2024-2034)
Figure 43. China Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 47. India Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Biologic Therapeutic Drug Market Share by Country (2024-2034)
Figure 50. Mexico Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Biologic Therapeutic Drug Market Share by Country (2024-2034)
Figure 53. Turkey Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Biologic Therapeutic Drug Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries